| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Passage Bio, Inc. (PASG) has 4 insiders with recent SEC Form 4 filings, including 11 buys and 4 sells. PASG is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 6.07M | $33.91M | - | |
| 10% | 623.7K | $3.49M | - | |
| CEO | 10.6K | $59.3K | - | |
| CFO | 7.5K | $41.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 | Goldsmith Bruce A | CEO And President | Buy | 10,000 | $3.15 | $31,500.00 | +167.1% | -26.5% | -65.0% | |
| Jan 20, 2022 | Orbimed Advisors LLC67 | 10% Owner | Buy | 369,100 | $5.42 | $2,000,522.00 | +5.9% | -45.0% | -66.3% | |
| Jan 19, 2022 | Orbimed Advisors LLC67 | 10% Owner | Buy | 168,300 | $5.38 | $905,205.00 | +0.9% | -47.2% | -68.4% | |
| Jan 13, 2022 | Orbimed Advisors LLC67 | 10% Owner | Buy | 150,000 | $5.61 | $841,082.00 | +0.8% | -43.1% | -70.0% | |
| May 21, 2021 | Goldsmith Bruce A | CEO And President | Buy | 2,000 | $13.12 | $26,230.00 | +50.2% | -21.8% | -85.2% | |
| May 21, 2021 | Morris Richard Steven | Chief Financial Officer | Buy | 2,171 | $13.82 | $29,999.53 | +66.1% | -21.8% | -85.2% | |
| Mar 15, 2021 | Romano Gary84 | Chief Medical Officer | Sale+OE | 10,000 | $21.10 | $211,012.62 | -86.1% | -30.2% | -86.2% | |
| Jan 20, 2021 | Quigley Jill M.63 | Chief Operating Officer | Sell | 1,300 | $30.01 | $39,011.05 | -0.4% | - | - | |
| Jan 14, 2021 | Quigley Jill M.63 | Chief Operating Officer | Sell | 16,298 | $30.10 | $490,569.80 | -5.2% | - | - | |
| Mar 24, 2020 | Countouriotis Athena | Director | Buy | 10,000 | $14.98 | $149,750.00 | +112.4% | - | - |